Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Inclusion Criteria: 1. single HCC of 5 cm or smaller; 2. three or fewer multiple HCC with a maximum dimension of 3 cm or less; 3. absence of portal vein thrombosis or extrahepatic metastases; 4. Child-Pugh classification A or B; 5. tumor accessible via a percutaneous approach. white blood cell count \>2 x 109/L, platelet count \>40 x 109/L,serum creatinine \<110 μmol/L, aspartate aminotransferase \<3 times the upper limit, serum bilirubin \<2.5 times the upper limit, prothrombin time \<19 seconds. Exclusion Criteria: 1. pregnant or breast-feeding; psychiatric problems, addiction, or any other disorder that prevented informed consent; 2. active uncontrolled infection; concurrent systemic corticosteroid treatment; 3. systemic autoimmune disease; 4. clinically significant ischemic heart disease or cardiac failure; 5. and chemotherapy or radiotherapy within the preceding 6 months